Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 3/2009

01-03-2009 | Research Article

Decrease in Serum Protein Carbonyl Groups Concentration and Maintained Hyperhomocysteinemia in Patients Undergoing Bariatric Surgery

Authors: T. Sledzinski, E. Goyke, R. T. Smolenski, Z. Sledzinski, J. Swierczynski

Published in: Obesity Surgery | Issue 3/2009

Login to get access

Abstract

Background

Human obesity is associated with oxidative stress but the factors contributing to the increase of reactive oxygen species (ROS) production remain unknown. We evaluated the association between serum homocysteine concentration, which may increase ROS production, and serum protein carbonyl groups concentration before and after bariatric surgery.

Methods

Serum protein carbonyl groups and serum homocysteine concentrations, as well as obesity markers, were compared in 18 obese patients before and 6 months after bariatric surgery. Ten healthy individuals with normal body mass index (BMI) served as controls.

Results

Before bariatric surgery, obese patients displayed approximately 50% higher serum protein carbonyl groups concentration than control subjects. After surgery, serum protein carbonyl groups concentration decreased and matched values observed in controls. Serum homocysteine concentration was also elevated in obese patients, but in contrast to protein carbonyl groups, did not change after surgery. The body weight, BMI, HOMA-IR, serum leptin, triacylglycerols, LDL/HLD cholesterol ratio, insulin, and glucose concentrations were higher in obese patients as compared to controls, and decreased after bariatric surgery.

Conclusions

This study demonstrates that bariatric surgery has protective effect on oxidative protein damage and improves several laboratory parameters including serum lipid concentration and insulin resistance. However, bariatric surgery does not cause a decrease in serum homocysteine concentration, a risk factor for the development of cardiovascular diseases. Collectively, the results presented in this paper suggest that serum homocysteine concentration is not directly associated with oxidative stress in obese patients after bariatric surgery.
Literature
1.
2.
Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond). 2006;30:400–18.CrossRef
3.
Dalle-Donne I, Aldini G, Carini M, et al. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med. 2006;10:389–406.CrossRefPubMed
4.
Dalle-Donne I, Rossi R, Giustarini D, et al. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329:23–38.CrossRefPubMed
5.
Konukoglu D, Serin O, Ercan M, et al. Plasma homocysteine levels in obese and non-obese subjects with or without hypertension; its relationship with oxidative stress and copper. Clin Biochem. 2003;36:405–8.CrossRefPubMed
6.
Ozata M, Mergen M, Oktenli C, et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem. 2002;35:627–31.CrossRefPubMed
7.
Van Gaal LF, Vertommen J, De Leeuw IH. The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects. Atherosclerosis. 1998;137(Suppl):S39–44: S39–S44.CrossRefPubMed
8.
Olusi SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord. 2002;26:1159–64.CrossRefPubMed
9.
Skrha J, Sindelka G, Kvasnicka J, et al. Insulin action and fibrinolysis influenced by vitamin E in obese Type 2 diabetes mellitus. Diabetes Res Clin Pract. 1999;44:27–33.CrossRefPubMed
10.
Kocic R, Pavlovic D, Kocic G, et al. Susceptibility to oxidative stress, insulin resistance, and insulin secretory response in the development of diabetes from obesity. Vojnosanit Pregl. 2007;64:391–7.CrossRefPubMed
11.
Asayama K, Nakane T, Dobashi K, et al. Effect of obesity and troglitazone on expression of two glutathione peroxidases: cellular and extracellular types in serum, kidney and adipose tissue. Free Radic Res. 2001;34:337–47.CrossRefPubMed
12.
Konukoglu D, Serin O, Turhan MS. Plasma total homocysteine concentrations in obese and non-obese female patients with type 2 diabetes mellitus; its relations with plasma oxidative stress and nitric oxide levels. Clin Hemorheol Microcirc. 2005;33:41–6.PubMed
13.
Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal. 2007;9:1941–58.CrossRefPubMed
14.
Perna AF, Ingrosso D, De Santo NG. Homocysteine and oxidative stress. Amino Acids. 2003;25:409–17.CrossRefPubMed
15.
Guzelmeric K, Alkan N, Pirimoglu M, et al. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome. Gynecol Endocrinol. 2007;23:505–10.CrossRefPubMed
16.
Ustundag B, Gungor S, Aygun AD, et al. Oxidative status and serum leptin levels in obese prepubertal children. Cell Biochem Funct. 2007;25:479–83.CrossRefPubMed
17.
Terruzzi I, Senesi P, Fermo I, et al. Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity? J Endocrinol Invest. 2007;30:747–53.CrossRefPubMed
18.
Uysal O, Arikan E, Cakir B. Plasma total homocysteine level and its association with carotid intima-media thickness in obesity. J Endocrinol Invest. 2005;28:928–34.CrossRefPubMed
19.
Kisakol G, Guney E, Bayraktar F, et al. Effect of surgical weight loss on free radical and antioxidant balance: a preliminary report. Obes Surg. 2002;12:795–800.CrossRefPubMed
20.
Uzun H, Zengin K, Taskin M, et al. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg. 2004;14:659–65.CrossRefPubMed
21.
Uzun H, Konukoglu D, Gelisgen R, et al. Plasma protein carbonyl and thiol stress before and after laparoscopic gastric banding in morbidly obese patients. Obes Surg. 2007;17:1367–73.CrossRefPubMed
22.
Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–78.CrossRefPubMed
23.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.PubMed
24.
Zabrocka L, Raczynska S, Goyke E, et al. BMI is the main determinant of the circulating leptin in women after vertical banded gastroplasty. Obes Res. 2004;12:505–12.CrossRefPubMed
25.
Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefPubMed
26.
Borson-Chazot F, Harthe C, Teboul F, et al. Occurrence of hyperhomocysteinemia 1 year after gastroplasty for severe obesity. J Clin Endocrinol Metab. 1999;84:541–5.CrossRefPubMed
27.
28.
Dixon JB, Dixon ME, O'Brien PE. Elevated homocysteine levels with weight loss after Lap-Band surgery: higher folate and vitamin B12 levels required to maintain homocysteine level. Int J Obes Relat Metab Disord. 2001;25:219–27.CrossRefPubMed
29.
Sheu WH, Wu HS, Wang CW, et al. Elevated plasma homocysteine concentrations six months after gastroplasty in morbidly obese subjects. Intern Med. 2001;40:584–8.CrossRefPubMed
30.
Williams DB, Hagedorn JC, Lawson EH, et al. Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis. 2007;3:8–13.CrossRefPubMed
31.
Zengin K, Taskin M, Sakoglu N, et al. Systemic inflammatory response after laparoscopic and open application of adjustable banding for morbidly obese patients. Obes Surg. 2002;12:276–9.CrossRefPubMed
32.
Dandona P, Mohanty P, Ghanim H, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab. 2001;86:355–62.PubMed
33.
Jacobsen DW. Hyperhomocysteinemia and oxidative stress: time for a reality check?. Arterioscler Thromb Vasc Biol. 2000;20:1182–4.CrossRefPubMed
34.
Rasheed Z, Ali R. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies. Life Sci. 2006;79:2320–8.CrossRefPubMed
35.
Gomez-Ambrosi J, Pastor C, Salvador J, et al. Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: effect of weight loss after gastric bypass. Obes Surg. 2007;17:585–91.CrossRefPubMed
36.
Malinowski SS. Nutritional and metabolic complications of bariatric surgery. Am J Med Sci. 2006;331:219–25.CrossRefPubMed
37.
38.
Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92:347–55.CrossRefPubMed
Metadata
Title
Decrease in Serum Protein Carbonyl Groups Concentration and Maintained Hyperhomocysteinemia in Patients Undergoing Bariatric Surgery
Authors
T. Sledzinski
E. Goyke
R. T. Smolenski
Z. Sledzinski
J. Swierczynski
Publication date
01-03-2009
Publisher
Springer New York
Published in
Obesity Surgery / Issue 3/2009
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9691-8

Other articles of this Issue 3/2009

Obesity Surgery 3/2009 Go to the issue

Review

Psychosocial Evaluation for Bariatric Surgery: The Boston Interview and Opportunities for Intervention

Research Article

Persistent Correlation of Ghrelin Plasma Levels with Body Mass Index Both in Stable Weight Conditions and during Gastric-bypass-induced Weight Loss

Case Report

Morbid Obesity and Subsequent Pancreatic Cancer: Pylorus-Preserving Pancreatoduodenectomy after Laparoscopic Sleeve Gastrectomy

Research Article

Laparoscopic Duodenal–Jejunal Exclusion in the Treatment of Type 2 Diabetes Mellitus in Patients with BMI < 30 kg/m2 (LBMI)

Research Article

Incidence of Anastomotic Strictures after Gastric Bypass: A Prospective Consecutive Routine Endoscopic Study 1 Month and 17 Months After Surgery in 441 Patients with Morbid Obesity

Research Article

Regulation of Bone Mineral Density in Morbidly Obese Women: A Cross-sectional Study in Two Cohorts Before and After Bypass Surgery